But until now, there hasnt been any data from large epidemiologic studies. Given the wide use of these drugs, these adverse events, although rare, must be considered by patients thinking about using them for weight loss. Mohit Sodhi To help fill this knowledge gap, UBC researchers examined health insurance claim records for approximately 16 million U.S
Glucagon-Like Peptide-1 (Glp-1) Agonists
Tendai Chiware of Genesis Fertility, now part of Pinnacle Fertility New York, was recently featured discussing the relationship between GLP-1 medications, fertility, and family planning
One study seems to suggest that Sermorelin may lead to an 82% increase in average growth hormone levels, which appeared to last for around two hours
Injections are available individually or as part of a wellness package